Terms: = Germ cell tumor AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Prognosis
71 results:
1. Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
Dhamdhere MR; Spiegelman VS
Front Immunol; 2024; 15():1385875. PubMed ID: 38660306
[TBL] [Abstract] [Full Text] [Related]
2. PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma.
Song M; Huang Y; Hong Y; Liu J; Zhu J; Lu S; Wang J; Sun F; Huang J; Xu J; Tang Y; Xia JC; Zhang Y
Oncoimmunology; 2024; 13(1):2289738. PubMed ID: 38125723
[TBL] [Abstract] [Full Text] [Related]
3. Asymmetric Adrenals: Sexual Dimorphism of Adrenal tumors.
Bechmann N; Moskopp ML; Constantinescu G; Stell A; Ernst A; Berthold F; Westermann F; Jiang J; Lui L; Nowak E; Zopp S; Pacak K; Peitzsch M; Schedl A; Reincke M; Beuschlein F; Bornstein SR; Fassnacht M; Eisenhofer G
J Clin Endocrinol Metab; 2024 Jan; 109(2):471-482. PubMed ID: 37647861
[TBL] [Abstract] [Full Text] [Related]
4. Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis.
Fanlo L; Gómez-González S; Rozalén C; Pérez-Núñez I; Sangrador I; Tomás-Daza L; Gautier EL; Usieto S; Rebollo E; Vila-Ubach M; Carcaboso AM; Javierre BM; Celià-Terrassa T; Lavarino C; Martí E; Le Dréau G
Oncogene; 2023 Jul; 42(28):2218-2233. PubMed ID: 37301928
[TBL] [Abstract] [Full Text] [Related]
5. Simultaneous nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomas.
Reuss DE; Downing SM; Camacho CV; Wang YD; Piro RM; Herold-Mende C; Wang ZQ; Hofmann TG; Sahm F; von Deimling A; McKinnon PJ; Frappart PO
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12915. PubMed ID: 37296499
[TBL] [Abstract] [Full Text] [Related]
6.
De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482
[TBL] [Abstract] [Full Text] [Related]
7. Comparative epigenomics by machine learning approach for neuroblastoma.
Sugino RP; Ohira M; Mansai SP; Kamijo T
BMC Genomics; 2022 Dec; 23(1):852. PubMed ID: 36572864
[TBL] [Abstract] [Full Text] [Related]
8. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma cells.
Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the prognosis of neuroblastoma in adolescents and adults: a case series and literature review.
Jin QY; Du SB; Yuan XJ
Neoplasma; 2022 Mar; 69(2):464-473. PubMed ID: 35068159
[TBL] [Abstract] [Full Text] [Related]
11. Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children's Cancer Group Neuroblastoma Committee (JCCG-JnbsG).
Ohira M; Nakamura Y; Takimoto T; Nakazawa A; Hishiki T; Matsumoto K; Shichino H; Iehara T; Nagase H; Fukushima T; Yoneda A; Tajiri T; Nakagawara A; Kamijo T
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053166
[TBL] [Abstract] [Full Text] [Related]
12. The quest to develop an effective therapy for neuroblastoma.
Bhoopathi P; Mannangatti P; Emdad L; Das SK; Fisher PB
J Cell Physiol; 2021 Nov; 236(11):7775-7791. PubMed ID: 33834508
[TBL] [Abstract] [Full Text] [Related]
13. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
[TBL] [Abstract] [Full Text] [Related]
14. Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma.
Kowalczyk JT; Wan X; Hernandez ER; Luo R; Lyons GC; Wilson KM; Gallardo DC; Isanogle KA; Robinson CM; Mendoza A; Heske CM; Chen JQ; Luo X; Kelly AE; Difilippantinio S; Robey RW; Thomas CJ; Sackett DL; Morrison DK; Randazzo PA; Jenkins LMM; Yohe ME
Mol Cancer Ther; 2021 Feb; 20(2):307-319. PubMed ID: 33158997
[TBL] [Abstract] [Full Text] [Related]
15. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
Meng X; Feng C; Fang E; Feng J; Zhao X
J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
[TBL] [Abstract] [Full Text] [Related]
16. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor prognosis of Glioblastoma.
Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
[TBL] [Abstract] [Full Text] [Related]
17. Vessel adherent growth represents a major challenge in the surgical resection of neuroblastoma and Is associated with adverse outcome.
Mühling J; Eberherr C; Müller Höcker J; Grote V; von Schweinitz D; Kappler R; Fröba-Pohl A
J Pediatr Surg; 2019 Nov; 54(11):2336-2342. PubMed ID: 31402147
[TBL] [Abstract] [Full Text] [Related]
18. FA-nbs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract] [Full Text] [Related]
19. Advances in the Surgical Treatment of Neuroblastoma.
Luo YB; Cui XC; Yang L; Zhang D; Wang JX
Chin Med J (Engl); 2018 Oct; 131(19):2332-2337. PubMed ID: 30246719
[TBL] [Abstract] [Full Text] [Related]
20. MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors.
Petroni M; Sardina F; Infante P; Bartolazzi A; Locatelli E; Fabretti F; Di Giulio S; Capalbo C; Cardinali B; Coppa A; Tessitore A; Colicchia V; Sahùn Roncero M; Belardinilli F; Di Marcotullio L; Soddu S; Comes Franchini M; Petricci E; Gulino A; Giannini G
Cell Death Dis; 2018 Aug; 9(9):895. PubMed ID: 30166519
[TBL] [Abstract] [Full Text] [Related]
[Next]
